Sponsors

Lead Sponsor

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

This research study is being done to study changes in muscle imaging over time in people with facioscapulohumeral muscular dystrophy (FSHD). Whole-body magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) will be used to evaluate skeletal muscle in study participants. This research is being done to assess how changes in muscle imaging correspond to muscle strength and function. Qualified participants will be asked to complete 5 study visits over 21 months. Each visit will include muscle strength and function testing in addition to the MRI/MRS scan. The investigators plan to use MRI and MRS in developing outcome measures that can be used in future clinical trials for FSHD.

Related studies

RECRUITINGPhase 1/2

Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy

Personalized Training for People With Rare Neuromuscular Disorders

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression

The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient Registry

Trial snapshot

Condition

Locations shown

For caregivers